Post-Essential Thrombocythemia Myelofibrosis clinical trials at UCSD
1 in progress, 0 open to new patients

• Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

  Sorry, in progress, not accepting new patients

  The purpose of this study is to determine the safety and tolerability of orally administered NS-018 in patients with Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (post-ET MF)

  San Diego, California and other locations

Last updated: March 27, 2018